Cases 1 - 10 of 21
ZS Pharma, Inc. et al v. Ascent Pharmaceuticals Inc. et al
as 1:2023cv01188
Plaintiff:
ZS Pharma, Inc. and AstraZeneca Pharmaceuticals LP
Defendant:
Ascent Pharmaceuticals Inc. and Hetero Drugs Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ZS Pharma, Inc. et al v. Ascent Pharmaceuticals Inc. et al
as 1:2022cv01099
Plaintiff:
ZS Pharma, Inc. and AstraZeneca Pharmaceuticals LP
Defendant:
Ascent Pharmaceuticals Inc. and Hetero Drugs Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co. Ltd. et al v. Hetero Labs Ltd. et al
as 1:2020cv01531
Defendant:
Hetero Labs Ltd., Honour Lab Ltd., Hetero Drugs Ltd. and others
Plaintiff:
Otsuka Pharmaceutical Co. Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Otsuka Pharmaceutical Co., Ltd. et al v. Hetero Labs Ltd. et al
as 1:2019cv01954
Defendant:
Hetero Labs Ltd., Honour Lab Ltd., Hetero Labs Ltd. Unit-V and others
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al. v. Hetero USA, Inc. et al.
as 1:2019cv00751
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Defendant:
Hetero Drugs, Ltd., Hetero USA Inc., Hetero Labs, Ltd. Unit-V and others
Cause Of Action: 35 U.S.C. § 271
GILEAD SCIENCES, INC. et al v. HETERO DRUGS LTD. et al
as 1:2016cv04938
Plaintiff:
GILEAD SCIENCES, INC. and EMORY UNIVERSITY
Defendant:
HETERO DRUGS LTD., HETERO LABS LTD. and HETERO USA INC.
Cause Of Action: 35 U.S.C. § 271
ELI LILLY AND COMPANY et al v. ACCORD HEALTHCARE, INC. USA et al
as 2:2014cv01643
Plaintiff:
ELI LILLY AND COMPANY , DAIICHI SANKYO CO., LTD. , DAIICHI SANKYO, INC. and others
Defendant:
ACCORD HEALTHCARE, INC. USA, ACCORD HEALTHCARE, INC., INTAS PHARMACEUTICALS LTD. and others
Cause Of Action: 35 U.S.C. § 271
ELI LILLY AND COMPANY et al v. ACCORD HEALTHCARE INC., USA et al
as 1:2014cv00389
Defendant:
ACCORD HEALTHCARE INC., USA, ACCORD HEALTHCARE, INC., ACTAVIS INC. and others
D/b/a ZYDUS CADILA:
CADILA HEALTHCARE LTD.
Counter Defendant:
DAIICHI SANKYO CO., LTD., DAIICHI SANKYO CO., LTD., DAIICHI SANKYO, INC. and others
Plaintiff:
DAIICHI SANKYO CO., LTD., DAIICHI SANKYO, INC., ELI LILLY AND COMPANY and others
Counter Claimant:
PAR PHARMACEUTICAL COMPANIES, INC., PAR PHARMACEUTICAL, INC. and TEVA PHARMACEUTICALS USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
JANSSEN PRODUCTS, L.P. et al v. HETERO DRUGS, LTD. et al
as 2:2013cv01444
Plaintiff:
JANSSEN PRODUCTS, L.P. and JANSSEN R&D IRELAND
Defendant:
HETERO DRUGS, LTD. , UNIT III and INVAGEN PHARMACEUTICALS, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
